Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
4559:TYO
Zeria Pharmaceutical Co Ltd
¥2,204.00
+0.55%
(+12.00) 1D
Apr 28, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4559...
Open
¥2,208
High
¥2,208
Low
¥2,180
Mkt. cap
110.46B
Avg. vol.
92.32K
Volume
94.60K
Dividend
2.18%
Quarterly dividend
¥12
Ex dividend date
Sep 29, 2025
P/E ratio
13.37
52-wk high
¥2,378
52-wk low
¥1,878
EPS
¥165
Shares outstanding
50.11M
No. of employees
2K
News stories
From sources across the web
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
22.54B
19.49B
20.47B
24.12B
Cost of goods sold
6.05B
5.58B
5.59B
6.38B
Cost of revenue
6.05B
5.58B
5.59B
6.38B
Research and development expenses
4.11B
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.58B
12.39B
12.76B
12.82B
Operating expense
14.54B
12.39B
12.76B
12.82B
Total operating expenses
20.59B
17.97B
18.35B
19.19B
Operating income
1.95B
1.52B
2.12B
4.93B
Other non operating income
-51.00M
25.00M
-23.00M
-81.04M
EBT including unusual items
2.16B
1.66B
994.00M
4.63B
EBT excluding unusual items
2.18B
1.66B
994.00M
4.63B
Income tax expense
397.00M
624.00M
383.00M
795.44M
Effective tax rate
18.34%
37.61%
38.53%
-
Other operating expenses
-
-
-
-
Net income
1.71B
1.09B
647.00M
3.82B
Net profit margin
7.59%
5.59%
3.16%
-
Earnings per share
-
-
-
-
Interest and investment income
95.00M
279.00M
30.00M
136.71M
Interest expense
-114.00M
-121.00M
-119.00M
-123.00M
Net interest expenses
-19.00M
158.00M
-89.00M
13.71M
Depreciation and amortization charges
5.85B
-
-
-
EBITDA
3.84B
3.41B
3.88B
6.81B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer